VERSANTIS
LIVE

Serial Number

79397393

Owner

GENFIT

Attorney

Ronald M. Kachmarik

Filing Date

Apr 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VERSANTIS Trademark

Serial Number: 79397393 • Registration: 7741625

VERSANTIS is a trademark filed by GENFIT on April 19, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENFIT (42 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

April 19, 2024

Registration Date

April 1, 2025

Published for Opposition

February 11, 2025

Goods & Services

Downloadable and recorded software for use in the management of cancer, metabolic diseases and liver diseases, namely, software for creating customized care plans for patients, for managing patient data, for providing clinical decision support information and analytics, for managing patient medications, and for providing reporting and analytics relating to patient care; downloadable and recorded software for use in research and development of new pharmaceutical products for others, namely, software for managing, analyzing and reporting on clinical trial data; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments particularly for recording, processing, reproducing, and transmitting data; data processing equipment; downloadable electronic publications in the nature of brochures, newsletters, reports, medical journals and medical periodicals, in the field of prevention, diagnosis and treatment of cancer, metabolic diseases and liver diseases; downloadable electronic databases in the field of prevention, diagnosis and treatment of cancer, metabolic diseases and liver diseases; all these goods exclusively in the field of liver and metabolic diseases.

Medical services; veterinary services; medical assistance; hospital services; consultation with respect to pharmacy, namely, pharmaceutical consultation; all these services exclusively in the field of liver and metabolic diseases.

Pharmaceutical research being research for the discovery of new medicines; scientific research, particularly in the medical, biomedical, and chemical field; consultation in the field of scientific research and development of therapies; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; all these services exclusively in the field of liver and metabolic diseases.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 30, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 12, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 31, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 14, 2025 FICS
FINAL DISPOSITION PROCESSED
Oct 14, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 2, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jun 19, 2025 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 1, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 1, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 8, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 31, 2024 GNFN
FINAL REFUSAL E-MAILED
Dec 31, 2024 GNFR
FINAL REFUSAL WRITTEN
Dec 31, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 14, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 8, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 7, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 1, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 14, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 13, 2024 REPR